Nanophase Technologies Corporation

NANX

US6300791018

Specialty Chemicals

Delayed OTC Markets Other stock markets 12:47:43 2024-05-15 pm EDT			5-day change	1st Jan Change
1.372 ^USD	+2.04%		-7.26%	+128.75%

Apr. 24	Transcript : Nanophase Technologies Corporation, Q1 2024 Earnings Call, Apr 24, 2024
Apr. 23	Nanophase Technologies Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Nanophase Technologies Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022

August 16, 2022 at 04:24 pm EDT

Nanophase Technologies Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 11.22 million compared to USD 7.11 million a year ago. Net income was USD 0.05 million compared to USD 0.041 million a year ago.
For the six months, revenue was USD 19.38 million compared to USD 14.19 million a year ago. Net income was USD 0.112 million compared to USD 1.35 million a year ago.

Latest news about Nanophase Technologies Corporation

Transcript : Nanophase Technologies Corporation, Q1 2024 Earnings Call, Apr 24, 2024	Apr. 24
Nanophase Technologies Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Transcript : Nanophase Technologies Corporation, Q4 2023 Earnings Call, Mar 21, 2024	Mar. 21
Nanophase Technologies Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Nanophase Technologies Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 20	CI
Nanophase Technologies Corporation announced that it expects to receive $6 million in funding	Feb. 29	CI
Nanophase Technologies Insider Bought Shares Worth $1,529,946, According to a Recent SEC Filing	Feb. 12	MT
Transcript : Nanophase Technologies Corporation, Q3 2023 Earnings Call, Nov 14, 2023	Nov. 14
Nanophase Technologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Transcript : Nanophase Technologies Corporation, Q2 2023 Earnings Call, Aug 03, 2023	23-08-03
Earnings Flash (NANX) NANOPHASE TECHNOLOGIES CORPORATION Reports Q2 Revenue $11.9M	23-08-02	MT
Nanophase Technologies Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02	CI
Mark E. Miller Joins Nanophase Technologies Corporation's Board of Directors, Effective as of July 19, 2023	23-07-20	CI
Transcript : Nanophase Technologies Corporation, Q1 2023 Earnings Call, May 12, 2023	23-05-12
Nanophase Technologies Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Earnings Flash (NANX) NANOPHASE TECHNOLOGIES CORPORATION Reports Q1 Revenue $9.5M	23-05-11	MT
Nanophase Technologies Corporation announced that it expects to receive $1.75 million in funding	23-04-30	CI
Transcript : Nanophase Technologies Corporation, Q4 2022 Earnings Call, Mar 30, 2023	23-03-30
Earnings Flash (NANX) NANOPHASE TECHNOLOGIES CORPORATION Posts Q4 Revenue $8.3M	23-03-29	MT
Nanophase Technologies Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-29	CI
Nanophase Technologies Corporation Auditor Raises 'Going Concern' Doubt	23-03-28	CI
Insider Buy: Nanophase Technologies	22-12-15	MT
Insider Buy: Nanophase Technologies	22-12-08	MT
Insider Buy: Nanophase Technologies	22-11-18	MT
Transcript : Nanophase Technologies Corporation, Q3 2022 Earnings Call, Nov 09, 2022	22-11-09

Chart Nanophase Technologies Corporation

Duration

Period

Chart Nanophase Technologies Corporation

More charts

Company Profile

Nanophase Technologies Corporation is engaged in minerals-based and scientifically driven healthcare solutions across beauty and life science categories. The Company offers soup-to-nuts production, from engineered materials, formulation development, and finished product development, to commercial manufacturing and packaging capabilities. Its capabilities in materials engineering allow it to coat and disperse materials on a nano and non-nano scale for use in a variety of markets in skin health, including for use in sunscreens as active pharmaceutical ingredients (APIs) and as fully developed skincare products, marketed and sold through its wholly owned subsidiary, Solesence, LLC. The Company manufactures and supplies metric tons of surface-engineered zinc oxide and titanium dioxide to its customers, and these are used by major global consumer products companies for sunscreens and skin health-focused personal care products. It also manufactures and sells advanced nanoparticle materials.

Sector

Specialty Chemicals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Specialty Chemicals

	1st Jan change	Capi.
NANOPHASE TECHNOLOGIES CORPORATION	+128.75%	73.79M
ECOLAB INC.	+17.45%	66.22B
SIKA AG	+3.54%	49.24B
GIVAUDAN SA	+18.03%	41.4B
FUJIFILM HOLDINGS CORPORATION	+21.48%	26.62B
EMS-CHEMIE HOLDING AG	+13.22%	19.84B
CELANESE CORPORATION	+2.20%	17.44B
ALBEMARLE CORPORATION	-11.47%	15.92B
POSCO FUTURE M CO., LTD.	-23.54%	15.57B
SYMRISE AG	+2.57%	15.45B

Other Specialty Chemicals